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Epiderxnal growth factor receptors (EGF-Rs) are ele-
· vated in active human psoriatic lesions, but decrease 
I in resolving lesions. Similar bio. logic responses in EGF-R levels have been demonstrated within human psoriatic skin grafted onto mice. We tested the hy-
pothesis that flaky-skin mice (fSII/fstl), one proposed I genetic animal model of psoriasis, would display 
EGF-R levels comparable to human psoriatic epider-
mis and show similar biologic responses. EGF-R lev-
els w ere characterized in unperturbed sites in jSII/fstl 
skin and +/? skin by enzyme-linked imlllunosorbent 
I assay, 125I_EGF binding, and immunostaining. Al-tered EGF-R levels were noted after mild trauma 
I (tape stripping) or under resolving conditions (30 
· doses o:f 50 mJ/cm2 ultraviolet B, 2.5 mg/kg oral 
I 
cyclosporin A, or daily 30 ILg/rnl topical EGF). In-
creased EGF-R inlmunostaining was observed in in-
volved flaky epidermal sites before treatment. To 
A lthough psoriasis is believed to havc a genetic basis that causes immunologic and. c.ytokine d y:s fun ctio l1 , the e tiology of this prohferatlve skin disease has remained a m ystery. During the last 1.0 y, the focus · of psoriatic studies has been directed at the an alysis I of disturban ces to an extremely diverse cyt~kiJl.e nem:or.k (Nick-
oloff, 1991). The cytokine pathway first studied 111 pson atlc leSIOns 
I was th e epidermal growth factor receptor (EGF-R) pathway. 
· Several g roups hypothesized that the prominent epiderm al hyper-
plasia was driven by overexpression within this pa thway. Initial 
Iltudies u sin g binding and immun ostaining techniques indic~ted t~lat EGF-R persisted throughout the epidermal compartment 111 aco ve 
psoria tic lesions (Nanney et ai , 1986) . Additional repo rts indicated 
[hat potential ligands, such as transforming growth factor (TGF)-a I and amphiregulin , were likewise increased in active lesions (Gott-
lieb et ai, 1988; Elder et ai, 1989; T urbitt et ai , 1990) . 
I Potential compl exities of cytokine interactions in this disease 
I were further. implicated by reports that EGF-R transmodulatlon by other cytokin e pathways, such as platelet-derived growth factor (Krane et ai, 1991b), insulin-like g row th facto r (Krane et ai, 1991a), 
I 
and TGF-f3 (Kane et ai, 1990; M assague, 1995), was also possible 
within p soriatic les ion s. Potential therapeutic re levance for the 
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I Surgery , 5 - 2221 MC N , Vanderbilt Mcdical Center. Nashvi ll e, TN 37232. Abbrevia tion: EGF- lt, epidermal growth f.1ctor receptor. 
I 
determine whether a hyperproliferative (Koebner) 
reaction could be induced, we tape stripped jSII/fSII 
tail and non-flaky dorsal sites. EGF-R levels in dorsal 
epidermis increased by days 3-4 after injury by en-
zyme-linked immunoabsorbent assay Inethods. When 
jSII/fs1l mice received one of three different treatments 
for 6 weeks, the skin returned to a normal phenotype 
both grossly and microscopically. Immunoreactive 
EGF-R in treated, but not untreated, sites decreased to 
either normal or nondetectable levels. These data indi-
cate that js II/fS 11 lllice exhibit an EGF-R profile identical 
to that of lesional and nonlesional human psoriatic 
epidermis. Modulations of the flaky phenotype in re-
sponse to injury and three different treatments suggest 
that jSII/fS1t is a useful in Idvo model for examining new 
treatment modalities for psoriasifornl skin diseases. KC)' 
lVords: psoriasis lIIodelljlak}I skill/CJ'clospOI~lI A /UYE/Koehllel' 
I'eactioll.] Illvest D el'lIIatoI106:1169-1174, 1996 
EGF-R pathway was pro vided by studies showing that pson atlc 
grafts on nude (/1/1 / /1/1) mice resolved in response to high doses of 
EGF (Nanney c ( ai, 1992b). Evidence that the EGF-R pathway is an 
integral component contributing to psoriatic pathophysio logy con-
tinues to accumulate fi-o m cl.inic:tl studi es showing a decrease in 
TGF-a in chronic plaque psorias is after a va riety of anti psoriatic 
treaonents (Watts et ai, 1994) and differen tial exp ression ofTGF- a 
and EGF-R in the transitional zone of lesions (Higashiyam a ct ai, 
1994). 
Elucidation of the mechanism s of psorias is has long been hin-
dered by constraints imposed by research on human patients and by 
the unavailability of suitable anim al models (Nickoloff et ai, 1995 ). 
R ecently, reports using spontaneous m o use mutations have pro-
duced compelling evidence that the fS lI( f.11I (flaky skin ) mu tation. 
w hich is an autosomal recessivc mu tation mapping to mouse 
chromosome 17, an d o ther mutants such as cpdll1 / cpdlll (chroni c 
pro li ferative dermatit.i s) , are indeed suitable animal models fo r 
studies of psoriatic mechanism s (HoganEsch c/ ai, 1. 993; Sundberg ct 
ai, 1994a, 1995). T he flaky- skin (lSI/ /js l/) mutation is characterized 
by marked acanthosis and hyperkeratosis w ith focal parakeratosis, 
neutrophilic infil tration in the epidermis accomp<l11ied by a prom-
inent dermal inflammatory infiltrate (Morita et ai, 1995) . jsl/lfw 
mice exhjbit increases in epidermal dendritic cells, suggestillg that 
this animal model also has immune-system abnormali ties (Sundberg 
ct ai, 1993) . T he psoriasiform phenotype is maintajned w hen 
fu ll-thickness grafts fi'om/qtl/w m ice are grafted onto nude (1/.1/ / 1/1/) 
mice (Sundberg ct ai , 1994b). T his mirro rs the responsc of human 
psoriatic grafts onto eith er 111/ / 1/1/ mice (Krueger ct ai, 1975) or 
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seidl scid mice (Nickoloff el aI, 1995) and adds c re den ce to th e theory 
th at psoriasis is not so le ly due to immunologic abnorm alities, but 
may also en tail intrinsic epidermal abnormalities. 
The purpose of tlus study was to investigate further the suitabili ty 
of th e f S/l I fsll mouse muta tion using a w e ll-studied tyrosine kinase 
cytokine receptor, EGF-R. We sough t to determine whether 
fs ,,1 fsll epidermis contain s abnormally hig h cytokine receptor levels, 
as do human p soriatic lesions (Nanney el aI, 1986). An additional 
goal was to evaluate biologic outcomes for EGF-R in fs ll lfsll in 
response to superficial trauma-induced proliferatio n (Koe bn er phe-
n o m enon) and in response to two standard , e ffec tive psoriatic 
the rapies and one exp erimenta l therapy. 
MATERIALS AND METHODS 
Animal Procedures Age-matched homozygous ([",lfSll) and heterozy-
gous or wild type (+ I fS /I or + I +, hereafte r referred to as + I ?) mice were 
supplied by T he J ackson Laboratory (Bar Harbor, ME) on the CBy. A/ j 
cOllgenic background. Before tape stripping of tails or wax depilation of the 
dorsum. I11ice \.vere anesthetized with an in tranluscular inj ection of ket-
amine plus acepromazine (200 mg/ kg + 2. 5 mg/kg). Electri c clippers were 
used to rcmove the dorsa l fur. and a razor was used to remove sparse hairs 
on tails. 
Koebnerization Mild mechanical trauma was applied to tail s using the 
tape-stripping model (Stoscheck ef nl , 1992). T his reproducib le injury. 
which was confirmed by histologic samples from each tai l, was produced by 
applying and removing masking tape (10 times). Mild trauma was also 
applied to 5 cm2 of dorsal skin by app li cation ofa wax depilatory (Zip W ax 
Hair R emove r; Lee Pharmaceuticals. Somh EI Monte, CAl heated to 
300°C. After the wax hardened , it was rapidl y lifted of!~ removing both 
outer squames and hair shafts. Mice (/s/lifs/l and + I? ) were di vided into 
groups and sacrificed at 1, 2, 3, 4, 7, and 14 d after wounding or were placed 
in a shanl treatJl1ent group. A miniI11Ul11 of six Inice were used for each tinle 
point. Animals were sacrifi ced with a O.S-ml intraperitoneal overdose of 
pentobarbital (70 mg/ml). All skin samples were divided and processed for 
both biochemical procedures and histologic sectioning. 
Psoriatic Treatment Regimens O ne postulated psoriatic treatmcnt, 
EGF (30 p.g/ml), was form ulated in a 2% methylcellulosc gel and deli vered 
topically for 42 d. T lus experimental treatment was selected because we 
have previously shown that EGF doses in tlus range inhibi t ep iderma l 
proliferation (Nanney, 1990; Nanney cf ai , 1992b). Oral cyclosporin A 
(CsA) (2 .5 mg/kg; Sandoz Pharmaceutical, Basal, Switzerland) was admin-
istered for 42 d in accordance with standard dosages (Christophers el ai , 
1992; Laburte el nl, 1992). For ultraviolet B (UVB) treatment, mice were 
placed in a cylindric tube with a 2-cm2 window and irradiated with 50 
mJlcm 2 (Na tional Biological Corp ., Twinsburg, O H) . Care was taken to 
irradiate only the dorsum. Phototherapy was delivered for 5 d pcr wk during 
a 6-wk peliod . A minimum of 10 mice were analyzed in each different 
treatment group. 
Reagents EGF was pllrchased from Upstate Biotechnologies , Inc. (Lake 
Placid , NY) , and ' 25 I_EGF was obtained from Amersham Corp (Arlington 
Heights, IL). NTB2 autoradiography emulsion was obtained fro m Eastman 
Kodak (Rochester, NY). Immunosupp lies were purchased from Vector 
Laborato ries (Burlingame, CA). 
Immunohistochemical Staining We used previously described immu-
nolustochemical sraining procedures for the identification of EGF-R (Nan-
ney ef ai , 1992b). A previo usly cha racterized polyclonal rabbi t antiserum 
(origina lly designated as number 163) and normal rabbit serum were used to 
identify immunoreacti ve EGF-R (Nanney ci ai , 1986). BrieRy, skin was 
fixed for 24 h in 4% paraforma ldehyde at 4°C and embedded in paraffin . 
Sections (6 p.m) were incubated overnight at 4°C in primary antisera or 
normal rabbit serum, and iml11unostaining was completed with an avid in-
biotin technique, followed by visuali zation with diaminobenzidine and 
Ma yer's henlatoxylin coun terstaining . Secti ons were viewed and photo-
graphed under an O lympus AJ-I2 light microscope. Negative controls were 
inc ubated in nornlal rabbit SCfml1 , as desc.ribed earlier. Positi ve in ternal 
control s included ventral un treated skin embedded in the same block and 
stain ed Sil11ultaneoll sly. Other inte rn al positive controls were 1l1 adc by 
examinlltion of untrea ted adj acent skin margins in the case of the EG F and 
UVB treatment groups. Nontreated normal mOuse skins were included in 
every inll11UI1ostaining experiment. 
EGF-R Enzyme-Linked Immunosorbent Assay (ELISA) and 1251_ 
EGF Binding Assay At the time of sacrifi ce. both dorsal and [;Til skin 
samples were removed. Triplicate punch biopsy spec imcns (8 mm2 ) were 
T HE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
incuba ted in 1 M NaBr, 5 mM ethylenediamine tetra acetic acid, pH 8.5, at 
37°C for 1 h to scparatc epidermis from dermis. After rinsing in di stilled 
water, the two la)'ers were peeled apart with forceps and used in the ELISA 
and binding assays. An intact complementary specimen was fixed, embed_ 
ded, and sta in ed w ith he matoxylin ;1nd cosi.n to confirm the exten t and 
reproducibility of wounding and to usc for immunohistochemistry. If 
wo unding proved too deep (bli stered epidermis) or superfi cial (stratum 
corneum still present) , subsequent biochemical data were discarded. 
EGF-Rs were quantitated using our previously described ELISA procedure 
(Stoscheck ef til, 1992). Determinations ofEGF-R leve ls were normalized to 
the amoun t of protein in the same area of epidermis. Binding sturlies were 
as reported previously (Nanney ef nl. 1984 . 1986). 
RESULTS 
Qualitative Responses to Mild Trauma (Koebnerization) 
R epresentative micrographs of the histo logic fea tures of dorsal 
flaky skin and thick tail skin b efore and after wax stripping are 
show n in Fig lA-H. Excessive scale on the dorsal surface offsllifill 
(Fig lA) as compared w ith + I? mice (Fig 1 G) is read ily appareut, 
as is an inc re ased inflamma to ry ce Ll in fi ltrate. Afte r trauma induced 
by wax stripping, a progressive thi ckening and acanthosis of dorsal 
epidermis was observed infsll lfsll nuce (Fig lB-D). By contrast , in 
the control g roup epidermal thickness was increased only tran_ 
sien tl y after wax stlipping and was no longer hypertrophic by 14 d 
afte r injury (Fig lH) . 
Unperturbed tail skin in fS lllfsll mice showed no phenotypic 
psoriasiform characteristi cs (Fig lE) . After a standard tape-strip-
ping injury, a progressive hypertroph y of tail epidermis was ob-
served. Previously, we showe d tha t normal tail epidermis resumes 
its pre wounding thickn ess b y 14 d after injury (Stoscheck el ai, 
1992), but in this study, the hyp ertrophy of fS lllfs ll tail ep idermis 
fa iled to resolve or thin during this identica l interval (Fig IF) . 
Quantitative Responses to Mild Trauma (Koebnerization) 
Binding studies w ere conducted to compare and contrast the staru 
of unoccupied EGF-Rs in dorsa l and tail epidermis. Dorsal non-
wounded epide rmis fromfsll lfs lI mice exlubited twice as much EGF 
binding as epidel111is £i'om control mice (Fig 2). After mild 
w ax-s tripping trauma , EGF binding in fmlfs lI mice showed an 
initial decline and late r an increase above base li.ne values, which 
p ers isted as lo ng as 14 d . By contras t, in normal mice EGF binding 
levels sh owed a transient rise at days 2-3 afte r mild trauma, a 
decline by day 7, and a retul11 to pre wounding levels by day 14 (Fig 
2) . 
In thicker epidermis of the tail, prcwounding values were tllree 
times lugher in fSt/1 fs ll epidermis than in control epidermis (Fig 3). 
After tape stripping, binding respon se patterns w ere similar be-. 
tween fS II.I fs ll and + I? epidermis, although til e absolute bindi.ng 
levels differed. A progressive increase iJl binding in both fl aky-skin 
mice and phen otypica lly normal mice was n oted that peaked at d ay 
3 and decl ined the reafter. 
To examine th e total numbe r ofEGF-Rs before and after trauma, 
we conducted an ELlSA assay on fS lllfsll and + I? d orsal epidermis 
(Fig 4) . Prewounding va lues were three times lug her in fsll lfsll 
d orsa l samples than in contro l mice. Levels for EGF-R in tail 
epidermis remained lugh after trauma and did n ot mirror the 
transient lise and fall w hich was previo usly o bserved in epidermis 
£i'om control luice (Stoscheck et ai, 1992) . At every experimental 
time examin ed, tota l levels ofEGF-R were higher in do rsal samples 
from fs ll l fsll than from contro l mice. 
Qua litative Responses to Antipsoriatic Treatments R epre-
sentative photomicrographs offslllfSll dorsal skin before treatmem 
are sho wn in Figs lA and SA. A photomicrograph of dorsal skin 
£i'omfslll fs ll mice after 6 wk o f topica l placebo treatments is sh own 
in Fig SB. Affected do rsal fS 1I1 fS II skin resumed a n ormal m ouse 
phen otyp e afte r 6 wk of UVB therapy (Fig SC), esA (data not 
shown) , or topica l EGF therapy (Fig SD) . A marked decrease in 
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Fjgure 1. Response (Koehner reaction) of dorsal skin to mild trauma inJslIlJslI and +/? mouse samples stained with h e matoxylin a nd eosin. 
A, befo r e trauma: thickened epidermis with a hyperkeratotic compartment. 13. day I after trau ma: removal of o uter epidermal layers, abnormally thi ck 
epidermis, and increased dermal cellulari ty. C, day 7 after trauma: outer epidermal remova l. increasing epiderm al thickness. and carl)' acanthosis . D . day 14 
after trauma : greatest increase in epidermal thickness and acanthosis. E, ta il skin before trauma in fm (f., " mice. F. ta il skin 14 dafter u'auma: epidennal 
thickness a nd a slight aC'lIIthosis remain in fs ll lf< 1I mice. G , dorsa l + 1' skin befo re traullla . H. dorsal + / ? skin 14 d after trauma . Scale liars, 50 fLm. 
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F igure 2. 125I_EGF binding in fSlllfslI and +/? dorsal e p idermis on 
days 1-14 after mild trauma. Binding remained static in fs lI /fs lI samples 
for 3 d. but increased above . teady-state levels o n da ys 7 and 14 aftcr 
wo unding. l3 indil1g ill control sa mp les increascd , but returned to steady-
sta tc levels by day 14. l3ascl inc binding in non wo unded (NW) fS II /fs lI skin 
was doublcd compared with contro ls. Data arc cxpressed as cpm/ f.Lg 
protei ll . m ean :!: SEM, II = 6. 
inAamm atol), ce ll infiltrates WaS also noted (Fig 5C,D) . No 
m o rpho logic alterations were noted in samples removed from + I? 
m ice after 6 wk of antipsoriatic therapies (data not shown) . 
Decreased hnmunohistochemical EGF-R After Antipsori-
atic Treatments R epresen tative micrograph s of fS lllfs l! dorsal 
skin and + I? do rsa l skin arc shown in F ig 6A,B. Immun oreactive 
EGF-Rs arc present in keratinocytes of both the interfollicu lar 
epidermis and epidermal appendages (Fig 6A) . T he thic ke ned 
appearance of the fS 1I1 fs l/ epidermis is appa ren t, as is the increased 
de rm al cellularity. Figure 6B illu strates the no rmally thin +I? 
epidermi s and shows prominent sta ining thro ughout tbe nuclea ted 
layers. T he sta tus of EGF immuno reacti vity after 6 wk of topica l 
EGF treatment is illustrated i.n fs l/ lfSII ski n (Fig 6C) and in +I? skin 
(Fig 6D) . In bo th types of skin , EGF-Rs are no longer detectable 
afte r continuous daily dosing w ith hig h EGF. In fslllfs lI skin 
receiving treatments, the exten t of the epiderma l compartment 
diminished g rea tly in thickn ess, as did dermal cellularity (Fig 6C) . 
After 6 wk ofCsA therapy,fsl/lfs lI mice also showed a decrease in 
e pide rmal thickn ess, although mi ldly immun oreactive EGF-Rs 
were sti ll detected . An identical pattern was observed in + I? skin 
sa mples . After 6 wk of uvn therapy, fS lllfsll epide rmis was 
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F igure 3 . 125I_EGF binding in tailfslllfslI and BALB/c epidermis Oil 
days 0-1 4 after mild trauma . l3 inding increased steadil y fo r 3 d in Is lI /js ll 
samp les, rcached a platea u at 3- 4 d, declined at day 7. and o ncc aga in 
increased at day 14 . Con tro l tai l epide rmis peaked o n day 3 and decreased 
be low prei nju ry level s. Prewoundin g (NW) binding in ISII /ISI! was three 
tim es hi g her than in cOll tro l epidc fllli s . Data are expressed as Cplll / p.g 
prote in . mcan :!: SEM , 11 = 6. 
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Figure 4 . Quantitatioll of EGF-R levels in dorsal fSllljslI epidermis 
on days 0-7 after mild trauma. EGF-R.s (no rmalized to 10' receptors 
per f.Lg protein; expressed as m ean :!: SEM) increased steadi ly, peaked at day 
3, and decreased at day 7. By con trast, base line va lues fo r fS II /fm ep idennis 
we re three times higher than in contro ls and showed slight increases after 
Ini ld trallIlla. For each l11 call, 11 = 6. 
som ewhat thinner than in pretrea tment samples, and EG F-Rs were 
bare ly de tec table (Fig 6F) . In control skin , EGF-R levels were 
e ither not detectabl e or m inimal (data not shown) . 
DISC USSION 
T his study suggests thatfslllfSl1 m ice have biolog ic and therapeutic 
responses typical of those o bserved in human psoriatic epidermis. 
M odulation of EGF-R after e ithe r mild trauma or antipsoriatic 
treatmen ts suggests that th e EGF-R pathway plays an active ro le in 
the initiatio n , maintenance, and regressio n of psoriasis. When 
involved (dorsal Aaky epidermis) and unin volved (tail epidermi ) 
skin samples were challenged by mi ld tra uma (Koebnerization) a 
sustain ed or pro longed increase in epide rmal thickness and EGF- R 
was indu ced . In the stra tum corneum of dorsa l skin , focal para-
ke ratosis, hyperkeratos is, and neutrophils ill both spontaneously 
flaky skin sites and superfi cial trauma-induced sites were observed. 
Figure 5 . Morphologic responses of dorsal f SlllfslI skin w ith and 
without 6 wk of anti psoriatic treatments stained with hemato":ylin 
and eosin. A , no ntreated dorsa l skin shows a sli ghtl y thickened epidemus 
and greatly expanded h yperke ratotic compartment. B. after topical placebo 
(2'Y. , methylcellulose) , a thi ckened epidermal com partment is present \Vim 
foca l parakeratosis, modest po lymorphonucl ea r infil tratio n , and an in-
creased cellula rity in the denni s. C. afte r UVI3 therapy, the epidermis i 
thinned w ith no evidence of abnonna li ties. D , after daily EGF (30 f.L /ml). 
the epidemli s is thi ck, with an o rthokeratotic pattern of differenti ation and 
no evidence of increasl!d de rmal ce llul ari ty. Scnle Ilfl/'S , 50 f.Lm . 
VOL. 106, NO. (. JU N E 19% 
I Figure 6. EGF-R localization in dorsal fSlllfslI skin after 6 wk of 
antipsoriatic treatments. A , before treatment, f Sll lfs lI sIGn shows a 
j
lhiCken e d e pidermal compartm ent with m oderate staining for EGF-Rs. Sc~le 
IaT, 25 J.Lnl . B, before treatment, contro l sIGn ( + I? ) shows a typIcally tlun 
epidennis a nd prominent EGF-R immunoreactivity. C, after daily topical 
EGF,jsll / fi n epidermis is th.ill , with no detectable EGF-R immunoreacti vity. 
I D, afte r d a ily topical EG F, contro l epidermis (+ I? ) is u.ncl~anged in . thinnes~ . but there is no detectable EGF- l'l. E. after esA therapy,)slI lfs lI ep,dcflms IS 
dUn, and EGF-Rs arc barely detectabl e. F. after UVB therapy. fS ll lfs lI 
epidermis i s thin, and no appreciable EG F-.R s arc detectable. B-F: scalI' bars, 
\10 /-Lm. 
In uninv olved t1uck skin o f fSl/ I js /l mice, a region comparable to 
human h ands and fee t, the re was also a sustained increase in 
epidenna l t1uckness but little or no flakin ess, only orthokeratosis. 
These data, as shown by four diffe ring techniques (immunostaining, 
EGF-R ELISAs, EGF binding, and phenotypic changes) , indicate 
, that in fi lll f SH mice, the response to injury is site specific, as 
observe d in human patients. 
I In our s tudies, treatment of active lesions in. fS /l1 js/l mi~e with high-dose topical EGF, UVE, or systemic CsA induced cl1J11cai and 
histologic remission of the flaky-skin phenotype as w ell as a 
normaliza tion o f immunoreactive EGF-R patterns. These findings I in rrllce complement previous studies on the EGF-R pathway in 
human p soriatic skin . Because of the limitations of using human 
I lubjects, human studies have no t been design ed o r conducte~ to deterrni n e whe ther overexpressed EGF-Rs are bIOlogIcally active. I When human psoriatic s ki~l was graft~d onto nude (/11/ / ,111) mice 
. and subsequently treated With 11Igh topical doses o f EGF, how ever, 
I 
histol? gic fe.atures, ClilLi.C, al fea tures., and overexpression of immu-
noreactive EGF-R returned to a normal pattern (Nal1l1ey ct "i , 
1992b) . T h ese same clinical. microscopic, and EGF-R pathway 
'I respon ses to high-dose, to pically applied EG F were o bserved in the 
present s tudies on fs" lfs" , confirming another feature common to 
both thi s nlouse m odel and human psoriatic lesions. 
The fi n / fs" m ouse model is at tractive for the stlldy o f psori-I w orm d e rmatoses. For example, both UVB and CsA trea tments 
[esult in r e mission of the flaky pheno type, a response similar to that 
I in human psoriasis. Although cellular targets fo r CsA w ere not 
addressed b y our study, remission o f diseased skin despite only a 
slight d ecr e ase in EGF-R sugges ts several possib le modes of action. 
CsA in th e murine m odel may be acting through e ither antilym-
phocytic (Elde r ct "i , 1993) o r antipro li fe ra tive mechanism s in 
keratinocy tes (Amsellem et "i , 1994), as it has been postulated to 
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fun ction in humans. Because CsA reportedly downregulates several 
cytokinesl recepto rs in cultured murine ke ratinocytes w hile having 
no effects on o the r cytokines (Won ct "i , 1994), its m ode of ac tion 
in the/w lfs" m odel remains unresolved in the present study. 
In terest in the role o f the immune system in pSOl; asis was based 
initially 0 11 tbe effects of UVB , to pical and systemic steroids, 
m e thotrexate , and , most recently, CsA on the skin-associated 
immune system (Ellis et " i, 1986; C hristophers c ( ai, 1992; Laburte 
ct ai , 1992) . T he recent focus on the hypothesis that activa ted T 
ce ll s can trigger psoriasis is exempli fie d by using an in terleukin-2 
fusion toxin to destroy activated T cells se lectively and to improve 
severe psoriasis clinically (Go ttleib c ( "i, 1995). T he fl aky-skin 
phen o type appears to be due to bOtil infl ammatory cell s and 
ke ratinocyte abnormaliti es . G raftin g of'/s" lfs" bone marrow into 
C E.17 scidlscid mice results in the development o f flaky skin . But 
double mutant js" ljs" scid/scid mice h ave only epide rmal abnornlal-
ities, without obvious immune abnormalities (Sundberg et ai, 1993). 
Full-thickness skin grafts fi'om ./s/l l fs" to seidl scid mice result in 
maintenance of the psoriasifo rm phenotype in the absence o f host T 
cells (Sundberg et "i , 1994b) . T hus, it sho uld b e emphasized that in 
eithe r the fs ,,1 fs" m odel o r in humans, it rem ains unknown how 
activated T cells in p soriatic lesions affect EGF-R o r how T cells arc 
activated by superficial epidermal trauma to modulate epiderm al 
thickness and EGF-R m etabo lism. 
Because two standard modes of psoriatic the rapy as w ell as one 
postulated therapeutic agent (EGF) induce a no rmaliza tion o f the 
fl aky- skin pheno type and a decrease in EG F-R levels, js ,t/fSH m ice 
appear to be a reasonable m odel to investiga te potential antipsori-
atic the rapies. The fl aky- skin mutation can be bred on to different 
mouse backgrounds that have a w ell-defin ed gen etic basis, includ-
ing those exhibitiJlg immunodefi ciency syndrom es o r cytokine 
abnormalities, to investiga te fa ctors controlling the indu ction, 
persisten ce , and resolu tion o f the fl aky- skin phenotype . T he clinical 
severity of the fl aky- skin phenotype, the presence o r absen ce of 
epidermal neutrophils , and the degree o f inflammation are depen-
dent on the background strain in wluch the flaky- skin muta tio n is 
m aintained (Sundberg et ai , 1995) . T hese data lend credence to the 
various degrees of severi ty of the clinical features of human psoriasis 
within a family pedigree, w hich are separate rrom the va rious 
clinical features o bse rved in a single patient, presumably du e to 
known and unknown gene ti c fac to rs, en vironmental factors and 
infec tious agents. Genetically, there is suppo rt fo r this cOl~cep t 
because there is a strain dependency fo r the expression of epi thelial 
defects in mice lacking the EG F-R (Sibilia and W agn er , 1995; 
T hreadgill et "i, 1995) . This is well known for m any othe r m ouse 
mutations with skin and hair abnormalities (Sundberg ct ai, 1995 ). 
T hese data collec ted from f m l iSll mice support our earlier 
hypo thesis tha t EGF-Rs are physiologically important in psoria tic 
lesions. Flaky- skin mice appear to exhibit abnorm alities in EG F-Rs 
that are m odulated in concert with the disease activity. T lus is 
simihlr to EG F-R patten1S w e have reported previo usly wi thin 
human psoriati c plaques (N anney et "i, 1986). Direc t treatment 
with higher (apparently inhibito ry) doses of EGF showed that EGF 
can m ediate the return to a normal pheno type, as repo rted previ-
ously in human lesio ns grafted onto nude mice (N anney et "i, 
1992b) . Al though this does no t directly prove tl, at EGF-R down-
regulates its own receptor expression , the immunohis toch emical 
patterns suggest that immunoreactive EGF-L"ls are indeed reduced 
in regressing lesions . Other groups have repo rted significant alter-
ations within the T GF-aIEGF-R pathway in psori ati c lesions. 
These changes include increased TG F- a in active les ions (Gottlieb 
ct "i , 1988 ; Elder et ai, 1989; T urbitt et "i, 1990) and decreasing 
leve ls in psoriatic patients receiving therapy (Watts cr "i, 1994) . 
N ew evidence from mouse mutations with targe ted disruption o f 
the EGF- R suggests that in the absence o f tbis receptor. epidennal 
prolife ration is severely retarded ( ibilia and W agn er, 1995; 
T hreadgill et "i, 199 5) . O verexpress iol1 o f the one ligand , T GF-a, 
in transgenic mice has resulted in benign hyperprolifera tive epider-
mis (Dominey et "i , 1993) . The flaky-skin m ouse m odel, with its 
documented abnormalities in EGF-R regulation , provides addi-
1174 NANNEY fiT AL 
tiona l eviden ce that epidermal misregu lation of one tyrosine kin ase 
receptor, EGF-R, is intimately in volved in the pathop hys iology of 
psoriasiform dermatoses . 
The "xpert t('r/Illical nssistnllce of Rat/d)1 StrOlwh, ) esse /3rilloll , nlld N allcy Cardll'ell 
is J!.rnllji dly nrk"() II,Je(~,!e(l . These stlldies lI'cre slIpl'ortl!d by (it e Dcpnr'mcllf oj 
Ve/ern lls' A.ff"nirs (L/3N, LEK) alld N atiOllnl I/IS/itll/es of Hea lth GM40437 
(L/3N) , 1'3 0 A R 4 1943 (LBN, LEK), AR40324 UPS) , nlld CA34 196 UPS). 
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